HDAX Therapeutics logo

HDAX Therapeutics

Website

Team & Investors

Leadership, board of directors, and investment partners

Executives
0
Board Members
0
Investors
28
Total Funding
$5.9M
Investors
28 investors across all rounds
A
AIM-HI
A
AmorChem
AQ
Anges Québec
AN
Archangel Network of Funds
BS
Berkeley SkyDeck
OTHER

+23 more investors

Sign in to view all

Explore More Data
Detailed analysis for HDAX Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

HDAX Therapeutics Leadership & Investors

HDAX Therapeutics is led by a team of experienced leaders. The company has attracted investment from 28 institutional and strategic investors.

Who Has Invested in HDAX Therapeutics?

HDAX Therapeutics has raised $5.9M from 28 investors including venture capital firms, private equity investors, and strategic partners.

Investment Opportunity

Accredited investors can access HDAX Therapeutics shares through secondary market platforms like Premier Alternatives, joining the company's existing institutional investor base.